Earth Science Tech Inc. (OTC: ETST) reported first-quarter results for the period ended June 30, 2026, showing revenue growth and significant gains in net income and operating cash flow. The company, which operates as a diversified holding company focused on the health and wellness sector, said the results reflect continued progress from its strategy of acquiring and scaling profitable healthcare, pharmaceutical, and telemedicine businesses.
Revenue rose 3% to $9.0 million, while gross profit increased 3.1% to $6.3 million. Net income climbed 57% to $715,697, and operating cash flow more than doubled to $707,131. Total assets grew 33.3% to $10.4 million compared with the same quarter last year. Management highlighted these figures as evidence of the company's ability to generate sustainable growth.
Looking ahead, Earth Science Tech plans to expand geographically, develop its telehealth and pharmacy fulfillment platforms, improve operating efficiency, and pursue greater institutional investor participation. The company's principal strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. Its healthcare operations are supported by investments in real estate and asset management activities and a consumer products business.
The company's value proposition centers on the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of specialized subsidiaries. For more details on the company's operations, visit www.EarthScienceTech.com. The full article on the Q1 results is available at https://ibn.fm/LBl8r.
The announcement matters for readers tracking health and wellness investments because it signals that integrated healthcare models—combining telemedicine and pharmacy services—can achieve profitability and scale. As patients increasingly seek convenient, direct-to-consumer healthcare options, companies like Earth Science Tech that bridge the gap between virtual care and medication fulfillment may be well-positioned to capture market share. The company's focus on operational efficiency and institutional investor outreach also suggests a potential pathway for growth in a competitive sector.
For ongoing news and updates, the company maintains a newsroom at https://ibn.fm/ETST. Additional information about BioMedWire, the specialized communications platform that distributed the announcement, can be found at https://www.BioMedWire.com.
